| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_555baa3cecf9a2c506027c15fb0165a6 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-556
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5011
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7072
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
| filingDate |
2000-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2008-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a34cd5471744e3c34850cdde943f865 |
| publicationDate |
2008-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-7419968-B1 |
| titleOfInvention |
Methods for treating therapy-resistant tumors |
| abstract |
This invention provides methods for using novel substituted pyrimidine compounds, derivatives and analogs thereof to treat diseases such as cancer. Examples of compounds and derivatives for use in the methods are (E)-5-(2-bromovinyl)-2′-deoxy-5′-uridyl phenyl L-alaninylphosphoramidate and (E)-5-(2-bromovinyl)-2′-deoxy-5′-uridyl phenyl L-alaninyl monophosphate. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011015147-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010222295-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009069268-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9427447-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014150688-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8859512-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8551965-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8329664-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9351970-B2 |
| priorityDate |
1999-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |